Biotech entrepreneurs across Asia are navigating funding gaps, weak innovation ecosystems, and unpredictable regulatory systems. For many, these challenges make it difficult to scale science-led businesses and deliver affordable healthcare solutions.

In this episode, host Gautam Kumra, Chairman of McKinsey Asia, sits down with Kiran Mazumdar-Shaw, Founder & Chairperson, Biocon Group. They discuss how she overcame a lack of funding, limited infrastructure, and regulatory hurdles to build one of Asia’s first and most successful biotech companies — pioneering affordable biosimilars, shaping biotech policy in India, and scaling purpose-driven innovation from the ground up.

The episode also features McKinsey partner Cheryl SH Lim, and Director of Learning, CEO Institute, Jennifer Chiang.

See www.mckinsey.com/privacy-policy for privacy information

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör McKinsey & Company. Innehållet i podden är skapat av McKinsey & Company och inte av, eller tillsammans med, Poddtoppen.